Workflow
华检医疗(01931)拟与华大共赢共同建立华检华大共赢创新药知识产权代币化基金
IVD MEDICALIVD MEDICAL(HK:01931) 智通财经网·2025-07-30 13:59

Core Viewpoint - The company has entered into a strategic cooperation framework agreement with BGI CoWin to establish an innovative drug intellectual property tokenization fund, aiming to enhance its role in reshaping the global medical innovation drug asset value chain [1][2] Group 1: Strategic Cooperation - The agreement involves the company and BGI CoWin collaborating to create the IVD-BGI CoWin fund, which will invest in projects under the NewCo + RWA Web3 exchange ecosystem model [1] - The company will act as a limited partner contributing to the fund, while BGI CoWin will serve as the general partner responsible for managing the fund [1] - BGI CoWin will identify high-quality innovative pharmaceutical companies or target assets that align with the company's strategic needs and provide services such as project promotion, due diligence, financing coordination, and transaction design [1] Group 2: Business Expansion Strategy - The board believes that this strategic cooperation will advance the company's business expansion through a three-pronged strategy of "NewCo + RWA + stablecoin" [2] - This approach is expected to strengthen the company's position in the global medical innovation drug asset value chain [2]